Beck, AJ;
Reddy, VM;
Sulkin, T;
Browne, D;
(2022)
Management of severe and symptomatic primary hyperparathyroidism in the first trimester of unplanned pregnancy.
Endocrinology, Diabetes and Metabolism Case Reports
, 2022
(1)
pp. 1-4.
10.1530/EDM-21-0203.
Preview |
PDF
Browne_Management of severe and symptomatic primary hyperparathyroidism in the first trimester of unplanned pregnancy_VoR.pdf - Published Version Download (393kB) | Preview |
Abstract
Primary hyperparathyroidism (PHP) is the most common aetiology for hypercalcaemia. The incidence of PHP in pregnant women is reported to be 8/100 000 population/year. It presents a threat to the health of both mother (hyperemesis, nephrolithiasis) and fetus (fetal death, congenital malformations, and neonatal severe hypocalcaemia-induced tetany). However, there is a lack of clear guidance on the management of primary hyperparathyroidism in pregnancy. In this study, we describe the case of a 26-year-old female patient who presented with severe hypercalcaemia secondary to PHP and underwent successful parathyroid adenectomy under local anaesthesia.
Archive Staff Only
 |
View Item |
